AltPep logo

AltPep

AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.

34 employees · est. 2019 · Seattle, United States

VS
KBP Biosciences logo

KBP Biosciences

At KBP we are consistently reminded that patient care is the end goal of what we do daily.

40 employees · est. 2007 · Princeton, United States

KBP Biosciences is the older company (2019 vs 2007).

Side-by-Side Comparison

AltPep KBP Biosciences
Founded
2019 2007 older
Headquarters
Seattle, United States Princeton, United States
Employees
34 40
Industry
Biotechnology Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B Series A
Total Funding
$78.10M $76.00M
Funding Rounds
3 1
Services
Development of diagnostics and therapeutics for amyloid diseases, Early detection and intervention for Alzheimer's and Parkinson's, Utilization of synthetic peptides for targeting b1-sheet toxic oligomers Not tracked yet
Target Customers
Healthcare providers, Biopharmaceutical companies, Neurologists, Research institutions Not tracked yet
Taxonomy
Biomedical Startup, Disease-modifying Treatments, Amyloid Diseases, Neurodegenerative Diseases, Type 2 Diabetes, Alpha-sheet Protein Structure, Alzheimer's Disease, Toxic Soluble Oligomers, Detection Tools, Medical Research, Innovative Approach Drug Discovery, Clinical Research, Therapeutic Areas, Organ Research, Antimicrobial Research, Immunology, Medical Research, Innovative Therapies, Unmet Medical Needs
Website
altpep.com kbpbiosciences.com
AltPep logo

About AltPep

AltPep is a biotechnology startup established in 2019, headquartered in the United States. The company specializes in developing early disease-modifying treatments and detection tools for amyloid diseases, focusing on toxic soluble oligomers, a key molecular trigger. This novel approach is backed by...

KBP Biosciences logo

About KBP Biosciences

KBP Biosciences is a biotechnology startup founded in 2007 and headquartered in the United States. The company's slogan "At KBP we are consistently reminded that patient care is the end goal of what we do daily" reflects its unwavering dedication to improving patient outcomes. KBP boasts a highly ex...

We will tell you when either one moves

BounceWatch watches AltPep and KBP Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AltPep and KBP Biosciences — by email.

Frequently Asked Questions

AltPep — AltPep develops early disease-modifying treatments and detection tools for amyloid diseases.. KBP Biosciences — At KBP we are consistently reminded that patient care is the end goal of what we do daily.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AltPep has raised $78.10M while KBP Biosciences has raised $76.00M.
AltPep and KBP Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AltPep with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AltPep on 12 Sep 2024, and KBP Biosciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy